Schonfeld Strategic Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$713K Buy
2,480
+494
+25% +$142K ﹤0.01% 1348
2025
Q1
$612K Sell
1,986
-2,414
-55% -$744K ﹤0.01% 1382
2024
Q4
$1.55M Sell
4,400
-1,733
-28% -$611K 0.01% 880
2024
Q3
$2.2M Sell
6,133
-14,389
-70% -$5.16M 0.01% 720
2024
Q2
$6.54M Sell
20,522
-65,101
-76% -$20.7M 0.04% 421
2024
Q1
$19.7M Buy
85,623
+1,028
+1% +$236K 0.13% 156
2023
Q4
$18.6M Buy
84,595
+35,523
+72% +$7.81M 0.12% 151
2023
Q3
$11.1M Buy
49,072
+9,672
+25% +$2.18M 0.09% 288
2023
Q2
$8.7M Buy
39,400
+7,631
+24% +$1.68M 0.07% 374
2023
Q1
$7.11M Sell
31,769
-48,649
-60% -$10.9M 0.07% 359
2022
Q4
$22.4M Buy
80,418
+54,790
+214% +$15.2M 0.19% 140
2022
Q3
$5.37M Sell
25,628
-2,195
-8% -$460K 0.04% 510
2022
Q2
$6.56M Buy
27,823
+25,923
+1,364% +$6.11M 0.06% 359
2022
Q1
$341K Sell
1,900
-11,300
-86% -$2.03M ﹤0.01% 1547
2021
Q4
$2.85M Sell
13,200
-12,430
-48% -$2.69M 0.03% 555
2021
Q3
$4.73M Buy
25,630
+21,930
+593% +$4.05M 0.05% 413
2021
Q2
$664K Sell
3,700
-9,800
-73% -$1.76M 0.01% 1026
2021
Q1
$2.26M Buy
+13,500
New +$2.26M 0.03% 598
2020
Q3
Sell
-2,171
Closed -$263K 1616
2020
Q2
$263K Sell
2,171
-4,306
-66% -$522K 0.01% 994
2020
Q1
$614K Buy
6,477
+470
+8% +$44.6K 0.04% 516
2019
Q4
$529K Sell
6,007
-67,096
-92% -$5.91M 0.01% 724
2019
Q3
$5.83M Buy
73,103
+60,503
+480% +$4.83M 0.17% 154
2019
Q2
$984K Buy
+12,600
New +$984K 0.03% 444
2018
Q3
Sell
-17,900
Closed -$2.03M 1012
2018
Q2
$2.03M Buy
+17,900
New +$2.03M 0.11% 265
2017
Q1
Sell
-1,600
Closed -$229K 747
2016
Q4
$229K Buy
+1,600
New +$229K 0.03% 482